Search results for

Writer Eric Deggans argues that it's just as easy to stereotype white, working-class people as folks of color. He's wondering: Why haven't we seen stronger protests of shows that stereotype whites?

Also: rare footage of William Faulkner; drag and Virginia Woolf; and the art of translation.

Although Boston's police chief says his department didn't know the FBI had investigated Tamerlan Tsarnaev's possible ties to extremists, the bureau says that information was entered into a database that local authorities could access.

Also: The local prosecutor reportedly may seek the death penalty against Ariel Castro, and also might file charges for every day of kidnapping and every act of sexual violence, among other offenses.

With its glittering spire now firmly attached, the new World Trade Center became the tallest building in the Western Hemisphere Friday morning.

How long can you go without checking email, or glancing at your smartphone? Clifford Nass, a psychology professor at Stanford University, says today's nonstop multitasking actually wastes more time than it saves--and he says there's evidence it may be killing our concentration and creativity too.

A Hollywood legend, he built cars for TV shows and movies, and customized rides for stars. It was Jeffries who painted James Dean's nickname — "Little Bastard" — on the Porsche 550 Sypder that the actor crashed in 1955. He was 80.

During the 2012 campaign, some organizations complained they were being unfairly scrutinized. A top IRS official said groups that included the words "tea party" or "patriot" in applications for tax-exempt status were subjected to additional reviews.

The comedian, also known for his work on The Daily Show and in films such as The 40-Year-Old-Virgin and Little Miss Sunshine, played paper company Dunder Mifflin boss Michael Scott on the hit NBC comedy series The Office for five years. He left the show in 2011.

Iin denying the government's motion for a stay, U.S. District Court Judge Korman, who has overseen the case since 2005, also laid out several substantive problems with the situation that last week's approval by the Food and Drug Administration created.